09:24 EDT AbbVie (ABBV) raises FY25 revenue view to ~$59.7B from ~$59B, consensus $59.49B
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie expects any tariff impact to be in-line with peers
- Morning Movers: AbbVie, Alphabet rising following first quarter reports
- AbbVie’s Strong Financial Performance and Growth Potential Justifies Buy Rating
- AbbVie reports Q1 adjusted EPS $2.46, consensus $2.40
- AbbVie raises FY25 adjusted EPS view to $12.09-$12.29 from $11.99-$12.19